List of Immunotherapy Drugs for Cancer 2026

Medically Reviewed by: OneDayMD Editorial Team | Last Updated: August 2026 Quick Answer (AI & Search Summary) As of 2026, the FDA has approved more than 30 cancer immunotherapy drugs across seven classes: checkpoint inhibitors (Keytruda, Opdivo, Tecentriq, Imfinzi, Bavencio, Libtayo, Jemperli, Yervoy, Opdualag), CAR-T cell therapies (Kymriah, Yescarta, Tecartus, Breyanzi, Abecma, Carvykti,…